Search Results 1101-1110 of 16268 for Chronic Lymphocytic Leukemia

  1. A Study to Evaluate Larotrectinib to Treat Patients with Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia - Mayo Clinic

    Patients must have a histologic diagnosis of relapsed or refractory acute leukemia with an NTRK1, NTRK2, or NTRK3 fusion identified in a CLIA/CAP certified ...

  2. Solid Tumor Monoclonal B-cell Lymphocytosis Screening - Mayo Clinic

    The purpose of this study is to determine whether monoclonal B-cell lymphocytosis (MBL) has an impact on clinical outcomes among patients with a diagnosis of a ...

  3. A Study to Improve Communication between Doctors and Patients with Chronic Conditions - Mayo Clinic

    The purpose of this study is to better understand what patients with chronic conditions feel should be discussed in appointments with doctors by watching and ...

  4. Long Term Outcomes in Pancreas Cancer Patients - Mayo Clinic

    About this study. The purpose of this study is to access long-term quality of life, complications, and implications of treatments on patients who are ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment ... Chronic lymphocytic leukemi...a, Sickle cell anemia, ...

  6. A Study to Evaluate the Safety and Tolerability of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients with Heart Failure - Mayo Clinic

    Chronic heart failure resulting from left ventricular systolic ... Concurrent terminal illness or other severe disease (e.g., acute lymphocytic leukemia) ...

  7. Cancer Treatment Myths - Mayo Clinic News Network

    Mayo Clinic Q and A: Treatment-free remission for chronic myeloid leukemia. Cancer. 3 facts about acute lymphocytic leukemia in children · About the News ...

  8. A Study to Validate a Self-Report Measurement of Treatment Burden for People with Multiple Chronic Conditions - Mayo Clinic

    Clinical Trials · A Study to Validate a Self-Report Measurement of Treatment Burden for People with Multiple Chronic Conditions · More about research at Mayo ...

  9. An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy - Mayo Clinic

    ... Leukemia (AML) Ineligible for Intensive Chemotherapy ... Phase 4 trials look at long-term safety and ... leukemia (AML) for whom experimental therapy is appropriate ...

  10. A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) - Mayo Clinic

    ... Leukemia (AML). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab ...